Timothy J. Saxon has been named vice president of Business Development at Enteris BioPharma. Mr. Saxon will serve as a member of Enteris’ executive leadership team and will lead partnering and licensing efforts to advance the clinical development and market expansion of the company’s oral peptide and small molecule delivery platform. Enteris plans to grow through its feasibility-to-licensing strategy in which it works jointly with pharma companies to leverage its Peptelligence platf...